oncology
Breast Cancer

Go ahead for funding of genetic tests for women

The MBS will fund genetic testing of women with hereditary mutations predisposing them to breast and ovarian cancers from 1 November. MBS funding for a seven-gene panel including BRCA 1 and 2 will also extend to family members of clinically affected women, according to a spokesperson from the Royal College of Pathologists of Australasia (RCPA). ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic